Drug Shortage Report for SANDOZ TOPIRAMATE TABLETS

Last updated on 2021-03-02 History
Report ID 131411
Drug Identification Number 02431815
Brand name SANDOZ TOPIRAMATE TABLETS
Common or Proper name SANDOZ TOPIRAMATE TABLETS
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) TOPIRAMATE
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100FCT BO V1 CA
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2021-01-08
Estimated end date 2021-02-26
Actual end date 2021-02-26
Shortage status Resolved
Updated date 2021-03-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-03-02 French Compare
v7 2021-03-02 English Compare
v6 2021-02-08 French Compare
v5 2021-02-08 English Compare
v4 2021-02-01 French Compare
v3 2021-02-01 English Compare
v2 2021-01-12 French Compare
v1 2021-01-12 English Compare

Showing 1 to 8 of 8